SILO PHARMA, INC. Tax Basis of Investments, Gross, Unrealized Appreciation
SILO PHARMA, INC. (SILO) had Tax Basis of Investments, Gross, Unrealized Appreciation of $170.19 thousand as of 2018-12-31, per its 10-K filed 2019-04-04.
Discontinued › Notes › Financial Services › Investment Company › Investment Company, Tax Disclosure Items › Investment, Tax Basis, Unrealized Gain (Loss)
us-gaap:TaxBasisOfInvestmentsGrossUnrealizedAppreciation · last filed 2019-04-04
- 2018-12-31: Tax Basis of Investments, Gross, Unrealized Appreciation $170.19K.
- 2017-12-31: Tax Basis of Investments, Gross, Unrealized Appreciation $1.19M.
| Period end | Tax Basis of Investments, Gross, Unrealized Appreciation |
|---|---|
| 2018-12-31 | $170.19K 10-K · filed 2019-04-04 |
| 2017-12-31 | $1.19M 10-K · filed 2019-04-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |